{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T09:32:29Z","timestamp":1773480749502,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jfo.2017.09.005","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T21:24:13Z","timestamp":1520457853000},"page":"122-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ciclosporine A topique et risque de n\u00e9oplasie de la surface oculaire"],"prefix":"10.1016","volume":"41","author":[{"given":"F.","family":"Rouimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bouillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Labb\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2017.09.005_bib0270","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","article-title":"Topical ophthalmic cyclosporine: pharmacology and clinical uses","volume":"54","author":"Donnenfeld","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2017.09.005_bib0275","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2017.09.005_bib0280","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00007890-199003000-00006","article-title":"Incidence of skin cancer after renal transplantation in The Netherlands","volume":"49","author":"Hartevelt","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.jfo.2017.09.005_bib0285","first-page":"189","article-title":"Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use","volume":"4","author":"Behnam","year":"2005","journal-title":"J Drugs Dermatol JDD"},{"key":"10.1016\/j.jfo.2017.09.005_bib0290","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000282871","article-title":"Tumors after renal transplantation","volume":"57","author":"Schmidt","year":"1996","journal-title":"Urol Int"},{"key":"10.1016\/j.jfo.2017.09.005_bib0295","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jfo.2017.09.005_bib0300","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jfo.2015.11.008","article-title":"[Topical cyclosporine in ophthalmology: pharmacology and clinical indications]","volume":"39","author":"Levy","year":"2016","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2017.09.005_bib0305","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00003226-199907000-00018","article-title":"Conjunctival epithelial neoplasias in organ transplant patients receiving cyclosporine therapy","volume":"18","author":"Macarez","year":"1999","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2017.09.005_bib0310","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/120347541201600517","article-title":"Conjunctival squamous cell carcinoma following psoriasis treatment","volume":"16","author":"Almousa","year":"2012","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jfo.2017.09.005_bib0315","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10792-012-9577-6","article-title":"Ocular surface squamous neoplasia in an immunosuppressed patient with atopic keratoconjunctivitis","volume":"32","author":"Flynn","year":"2012","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2017.09.005_bib0320","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/ICL.0b013e31829e905e","article-title":"Papilloma development and long-term ciclosporin use in chronic ocular allergy with associated keratoconus","volume":"39","author":"Manzouri","year":"2013","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jfo.2017.09.005_bib0325","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1600-0420.2007.01046.x","article-title":"Prolonged exposure to topical cyclosporine A does not seem to promote conjunctival malignancy","volume":"86","author":"B\u00f6hringer","year":"2008","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.jfo.2017.09.005_bib0330","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.ophtha.2005.05.013","article-title":"safety evaluation of cyclosporine 0.1\u00a0% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3\u00a0years","volume":"112","author":"Barber","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.09.005_bib0335","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jfo.2015.02.008","article-title":"Collyres de ciclosporine\u00a0: \u00e9tude d\u2019une cohorte de patients de 2009\u00a0\u00e0 2013","volume":"38","author":"Kauss Hornecker","year":"2015","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2017.09.005_bib0340","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","article-title":"Efficacy and safety of topical 0.05\u00a0% cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis","volume":"13","author":"Wan","year":"2015","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jfo.2017.09.005_bib0345","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/bjophthalmol-2013-304072","article-title":"Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease","volume":"98","author":"Sacchetti","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.09.005_bib0350","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/ICO.0000000000000123","article-title":"Topical cyclosporine A in the treatment of dry eye: a systematic review and meta-analysis","volume":"33","author":"Zhou","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2017.09.005_bib0355","first-page":"0","article-title":"One-year efficacy and safety of 0.1\u00a0% cyclosporine A cationic emulsion in the treatment of severe dry eye disease","author":"Baudouin","year":"2017","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.09.005_bib0360","first-page":"0","article-title":"A randomized study of the efficacy and safety of 0.1\u00a0% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye","author":"Baudouin","year":"2017","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.09.005_bib0365","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5301\/ejo.5000779","article-title":"Efficacy and safety of 0.1\u00a0% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial","volume":"26","author":"Leonardi","year":"2016","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.09.005_bib0370","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.0022-202X.2005.23858.x","article-title":"Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation","volume":"125","author":"Yarosh","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jfo.2017.09.005_bib0375","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/j.1600-6143.2008.02386.x","article-title":"Skin cancer in organ transplant recipients \u2013\u00a0where do we stand today?","volume":"8","author":"Ulrich","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jfo.2017.09.005_bib0380","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2230.2008.02763.x","article-title":"Effects of oral administration of ciclosporin A on skin carcinogenesis: a study using the two-stage carcinogenesis protocol in mice","volume":"33","author":"Yajima","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jfo.2017.09.005_bib0385","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0041-1345(98)00577-6","article-title":"Calcineurin and the biological effect of cyclosporine and tacrolimus","volume":"30","author":"Halloran","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jfo.2017.09.005_bib0390","doi-asserted-by":"crossref","first-page":"e0159983","DOI":"10.1371\/journal.pone.0159983","article-title":"In vitro inhibition of NFAT5-mediated induction of CCL2\u00a0in hyperosmotic conditions by cyclosporine and dexamethasone on human hela-modified conjunctiva-derived cells","volume":"11","author":"Warcoin","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jfo.2017.09.005_bib0395","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2174\/0929867033457160","article-title":"Cyclophilin D as a drug target","volume":"10","author":"Waldmeier","year":"2003","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jfo.2017.09.005_bib0400","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.ico.0000133994.22392.47","article-title":"Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca","volume":"24","author":"Strong","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2017.09.005_bib0405","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.mehy.2004.03.030","article-title":"Molecular effects of cyclosporine and oncogenesis: a new model","volume":"63","author":"Andr\u00e9","year":"2004","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jfo.2017.09.005_bib0410","first-page":"173","article-title":"applied topically to the recipient eye inhibits corneal graft rejection","volume":"45","author":"Hunter","year":"1981","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jfo.2017.09.005_bib0415","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-2008-1050995","article-title":"[Local treatment of corneal transplants in the human with cyclosporin A]","volume":"187","author":"Hoffmann","year":"1985","journal-title":"Klin Monatsbl\u00e4tter F\u00fcr Augenheilkd"},{"key":"10.1016\/j.jfo.2017.09.005_bib0420","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1399-3038.2006.00427.x","article-title":"Efficacy of 1.25\u00a0% and 1\u00a0% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood","volume":"17","author":"Spadavecchia","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jfo.2017.09.005_bib0425","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0161-6420(98)99043-1","article-title":"A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis","volume":"105","author":"Hingorani","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.09.005_bib0430","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12325-009-0037-2","article-title":"Efficacy of topical cyclosporine for the treatment of ocular rosacea","volume":"26","author":"Schechter","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.jfo.2017.09.005_bib0435","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3\u00a0Study Group","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.09.005_bib0440","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/10807680260362696","article-title":"Blood concentrations of cyclosporin a during long-term treatment with cyclosporin a ophthalmic emulsions in patients with moderate to severe dry eye disease","volume":"18","author":"Small","year":"2002","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2017.09.005_bib0445","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0039-6257(05)80054-2","article-title":"Ocular surface squamous neoplasia","volume":"39","author":"Lee","year":"1995","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2017.09.005_bib0450","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1442-9071.1997.tb01514.x","article-title":"Retrospective study of ocular surface squamous neoplasia","volume":"25","author":"Lee","year":"1997","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.09.005_bib0455","first-page":"893","article-title":"Corneo-conjunctival carcinoma in Uganda","volume":"20","author":"Waddell","year":"2006","journal-title":"Eye Lond Engl"},{"key":"10.1016\/j.jfo.2017.09.005_bib0460","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.exer.2014.10.015","article-title":"Pathophysiology of ocular surface squamous neoplasia","volume":"129","author":"Gichuhi","year":"2014","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jfo.2017.09.005_bib0465","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2147\/OPTH.S1606","article-title":"Topical treatment options for conjunctival neoplasms","volume":"2","author":"Kim","year":"2008","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"10.1016\/j.jfo.2017.09.005_bib0470","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/tmi.12203","article-title":"Epidemiology of ocular surface squamous neoplasia in Africa","volume":"18","author":"Gichuhi","year":"2013","journal-title":"Trop Med Int Health TM IH"},{"key":"10.1016\/j.jfo.2017.09.005_bib0475","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00003226-200303000-00011","article-title":"Squamous cell carcinoma of the conjunctiva in patients with atopic eczema","volume":"22","author":"Heinz","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2017.09.005_bib0480","first-page":"808","article-title":"[Atopic keratoconjunctivitis: probably a risk factor for the development of conjuntival carcinoma]","volume":"100","author":"Kallen","year":"2003","journal-title":"Ophthalmol Z Dtsch Ophthalmol Ges"},{"key":"10.1016\/j.jfo.2017.09.005_bib0485","first-page":"1182","article-title":"Conjunctival intra-epithelial neoplasia occurring in young patients with asthma","volume":"24","author":"Rundle","year":"2010","journal-title":"Eye Lond Engl"},{"key":"10.1016\/j.jfo.2017.09.005_bib0490","doi-asserted-by":"crossref","first-page":"592980","DOI":"10.4061\/2010\/592980","article-title":"Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair","volume":"2010","author":"Rastogi","year":"2010","journal-title":"J Nucleic Acids"},{"key":"10.1016\/j.jfo.2017.09.005_bib0495","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.mrfmmm.2005.04.005","article-title":"Regulation of DNA damage recognition and nucleotide excision repair: another role for p53","volume":"577","author":"Ford","year":"2005","journal-title":"Mutat Res"},{"key":"10.1016\/j.jfo.2017.09.005_bib0500","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1440-1711.2001.01047.x","article-title":"Ultraviolet light induced injury: immunological and inflammatory effects","volume":"79","author":"Clydesdale","year":"2001","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jfo.2017.09.005_bib0505","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1006\/viro.1999.9950","article-title":"Induction of E6\/E7\u00a0expression in cottontail rabbit papillomavirus latency following UV activation","volume":"263","author":"Zhang","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.jfo.2017.09.005_bib0510","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1073\/pnas.95.5.2290","article-title":"Human papillomavirus type 16\u00a0E6\u00a0and E7\u00a0oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways","volume":"95","author":"Song","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jfo.2017.09.005_bib0515","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/carcin\/24.2.159","article-title":"Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins","volume":"24","author":"Helt","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jfo.2017.09.005_bib0520","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jfo.2017.09.005_bib0525","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jfo.2017.09.005_bib0265","first-page":"254","article-title":"Incidence of squamous-cell carcinoma of the conjunctiva and other eye cancers in the NIH-AARP Diet and Health Study","volume":"6","author":"Emmanuel","year":"2012","journal-title":"Ecancermedicalscience"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551217304849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551217304849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:07:31Z","timestamp":1759259251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551217304849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0181551217304849"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2017.09.005","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ciclosporine A topique et risque de n\u00e9oplasie de la surface oculaire","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2017.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}